ENMD-2076
Product Specifications
CAS Number
934353-76-1
Target
Aurora Kinase
Applications
Cell Cycle
Smiles
CC1=CC (=NN1) NC2=CC (=NC (=N2) C=CC3=CC=CC=C3) N4CCN (CC4) C
Molecular Formula
C21H25N7
Additionnal Information
ENMD-2076 has selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.86 nM, 25-fold selective for Aurora A than over Aurora B and less potent to RET, SRC, NTRK1/TRKA, CSF1R/FMS, VEGFR2/KDR, FGFR and PDGFRα. ENMD-2076 inhibits the growth of a wide range of human solid tumor and hematopoietic cancer cell lines with IC50 from 0.025 to 0.7 μM, which induces apoptosis and G2/M phase arrest. Phase 2.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15376951 1 Vial
Lentiviral human SHISAL2B sgRNA gene knockout kit - Lentiviral human SHISAL2B sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 
GTR15401387 1 Vial
Lentiviral human ADGRD1 sgRNA gene knockout kit - Lentiviral human ADGRD1 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details